NCT06230393

Brief Summary

The purpose of this study is to evaluate long term safety and effectiveness of the STREAMLINE® SURGICAL SYSTEM

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jun 2024

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 19, 2024

Completed
11 days until next milestone

First Posted

Study publicly available on registry

January 30, 2024

Completed
4 months until next milestone

Study Start

First participant enrolled

June 1, 2024

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 4, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 4, 2025

Completed
Last Updated

March 30, 2026

Status Verified

March 1, 2026

Enrollment Period

1.5 years

First QC Date

January 19, 2024

Last Update Submit

March 24, 2026

Conditions

Keywords

Intraocular PressureGlaucomaMIGS

Outcome Measures

Primary Outcomes (1)

  • Change in IOP

    From Screening to annual endpoints

    24months; 36 months; 48months, 60 months

Secondary Outcomes (1)

  • Number of IOP lowering medications

    24months; 36 months; 48months, 60 months

Interventions

STREAMLINE® SURGICAL SYSTEM

Eligibility Criteria

Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Subjects who participated in the DF6-CL-20-01 trial

You may qualify if:

  • participated in the DF6-CL-20-01 trial.

You may not qualify if:

  • lost to follow up in the DF6-CL-20-01 trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinica 20/20

San José, Costa Rica

Location

MeSH Terms

Conditions

Glaucoma, Open-AngleGlaucoma

Condition Hierarchy (Ancestors)

Ocular HypertensionEye Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 19, 2024

First Posted

January 30, 2024

Study Start

June 1, 2024

Primary Completion

December 4, 2025

Study Completion

December 4, 2025

Last Updated

March 30, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations